Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia-Reference-Cited by-同舟云学术

Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia

Published:2003-10 Issue:6 Volume:14 Page:357-360
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Damci Taner,Tatliagac Serkan,Osar Zeynep,Ilkova Hasan

Publisher

Elsevier BV

Subject

Internal Medicine

Reference17 articles.

1. Diabetic dyslipidemia;Taskinen;Atheroscler Suppl,2002

2. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The bezafibrate infarction prevention (BIP) study;Behar;Circulation,2000

3. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study;Lancet,2001

4. Concurrent reductions in serum leptin and lipids during weight loss in obese men with type II diabetes;Halle;Am J Physiol (Endocrinol Metab),1999

5. Lipotoxicity and glucotoxicity in type 2 diabetes, effects on development and progression;Sivitz;Postgrad Med,2001

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Fibrate Treatment on Circulating Adipokine Levels: A Systematic Review and Meta-analysis of Randomized Clinical Trials;Archives of Medical Research;2024-02

2. Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, “futile” fatty acid cycling, and FADH2 oxidation;GeroScience;2024-01-25

3. Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study;Pharmaceutics;2023-06-27

4. Leptin signaling in breast cancer and its crosstalk with peroxisome proliferator-activated receptors α and γ;Clinical and Translational Oncology;2022-11-08

5. The synergistic ameliorative activity of peroxisome proliferator‐activated receptor‐alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance;Ibrain;2022-08-08